BioWorld MedTech

May 26, 2010

View Archived Issues

In a challenging environment, the top-quality deals get done

MINNEAPOLIS – With the initial public offering (IPO) window essentially nailed shut over the past two-plus years, corporate buyers have held the keys to the exit for venture-backed companies. (Medical Device Daily) Read More

Sharfstein acknowledges need to address safety with public

Read More

Doctors embrace innovation in new generation of stents

Read More

Test predicts likelihood of prostate cancer reoccurrence

Read More

Stentys wins CE mark for its self-expanding DES

Read More

MDD's food for med tech thought

Read More

RVO receives $35M funding; Phreesia closes $16M round

Read More

SunTech's blood pressure technology chosen by Damec

Read More

People in the News

Read More

Exactech acquires Brighton in $5.5M all-cash transaction

Read More

Firm investigates Odyssey for possible fiduciary breach

Read More

Product Briefs

Read More

Boston Sci's PTCA catheter gains CE mark, FDA approval

Read More

MDD's Oncology Extra

Read More